--- title: "David V Daniels, M.D. | Sutter Health" url: "https://www.sutterhealth.org/research/investigators/david-v-daniels-md-1049681155" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Investigators](https://www.sutterhealth.org/research/investigators) / 4. David V Daniels, M.D. ![David V Daniels, M.D.](https://dyn.mktgcdn.com/p/4FqLGwv5l5KnP42Q-6toojBNRGEKTDrprUK_xsYZSo8/fit=crop,gravity=auto,dpr=2,width=240,height=240) # David V Daniels, M.D. Investigator [View profile](https://www.sutterhealth.org/find-provider/dr-david-daniels-1046234487) Dr. David V. Daniels is a leading structural heart surgeon and innovator with more than a decade of experience advancing transcatheter therapies. As Co‑Director of the Structural Heart Program at Sutter Health Bay Area and director of the CPMC Cardiac Cath Lab, he oversees more than 300 TAVR procedures annually and has built one of the region’s highest‑performing multidisciplinary programs. A recognized expert in acute mechanical circulatory support and complex structural interventions, he is also a top enroller in cardiovascular device trials and serves as Global Principal Investigator for the ENCIRCLE study—the first transseptal TMVR system to reach approved human use. Dr. Daniels is the founder and CEO of Solo Pace Inc., a medical device startup developing transformative technologies for TAVR efficiency and post‑procedure heart block management. He previously led a 100‑physician cardiovascular organization and continues to shape the field through prolific research, publications, and faculty roles. 1501 Trousdale Drive Burlingame, CA 94010 ## Clinical trials - Clinical trial ### [Aortic Regurgitation - Transcatheter Aortic Valve Replacement (TAVR) vs Surgical AV Replacement ARTIST](https://www.sutterhealth.org/research/clinical-trials/aortic-regurgitation-transcatheter-aortic-valve-replacement-tavr-vs-surgical-av-replacement-artist-2023208580) A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Transcatheter Heart Valve System Versus Surgical Valve Replacement in Patients With Aortic Regurgitation (ARTIST) (Protocol JVT24001) **Status:** Open to Enrollment - Clinical trial ### [Aortic Regurgitation J-Valve JOURNEY](https://www.sutterhealth.org/research/clinical-trials/aortic-regurgitation-j-valve-journey-2041489906) J-Valve to Treat Aortic Regurgitation Via Transcatheter Therapy **Status:** Closed to Enrollment - Clinical trial ### [Aortic Stenosis Severe SAPIEN X4 Transcatheter Heart Valve ALLIANCE](https://www.sutterhealth.org/research/clinical-trials/aortic-stenosis-severe-sapien-x4-transcatheter-heart-valve-alliance-2080559769) Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve **Status:** Open to Enrollment - Clinical trial ### [Aortic Stenosis with TAVI ET03 SHIELD](https://www.sutterhealth.org/research/clinical-trials/aortic-stenosis-with-tavi-et03-shield-2084630343) A Prospective, Randomized, Multicenter, Single-blind Trial to Assess the Safety and Effectiveness of the Encompass F2 Cerebral Protection System Vs. Standard of Care (Unprotected or Sentinel® Cerebral Protection System) During Transfemoral Transcatheter Aortic Valve Replacement **Status:** Coming Soon - Clinical trial ### [Aortic Valve Stenosis SAPIEN X4 Transcatheter Heart Valve ALLIANCE-AVIV](https://www.sutterhealth.org/research/clinical-trials/aortic-valve-stenosis-sapien-x4-transcatheter-heart-valve-alliance-aviv-2080559940) Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves **Status:** Open to Enrollment Page 1 of 2 ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/investigators/david-v-daniels-md-1049681155#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Investigators","item":"https://www.sutterhealth.org/research/investigators"},{"@type":"ListItem","position":4,"name":"David V Daniels, M.D."}]} ``` ```json {"@context":"https://schema.org","@type":"ProfilePage","@id":"https://www.sutterhealth.org/research/investigators/david-v-daniels-md-1049681155#profilepage","url":"https://www.sutterhealth.org/research/investigators/david-v-daniels-md-1049681155","name":"David V Daniels, M.D.","dateModified":"2026-06-03","breadcrumb":{"@id":"https://www.sutterhealth.org/research/investigators/david-v-daniels-md-1049681155#breadcrumblist"},"primaryImageOfPage":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/4FqLGwv5l5KnP42Q-6toojBNRGEKTDrprUK_xsYZSo8/460x460.webp","width":460,"height":460},"mainEntity":{"@id":"https://www.sutterhealth.org/research/investigators/david-v-daniels-md-1049681155"}} ``` ```json {"@context":"https://schema.org","@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/david-v-daniels-md-1049681155","name":"David V Daniels, M.D.","givenName":"David","additionalName":"V","familyName":"Daniels","honorificSuffix":"M.D.","description":"Dr. David V. Daniels is a leading structural heart surgeon and innovator with more than a decade of experience advancing transcatheter therapies. As Co‑Director of the Structural Heart Program at Sutter Health Bay Area and director of the CPMC Cardiac Cath Lab, he oversees more than 300 TAVR procedures annually and has built one of the region’s highest‑performing multidisciplinary programs. A recognized expert in acute mechanical circulatory support and complex structural interventions, he is also a top enroller in cardiovascular device trials and serves as Global Principal Investigator for the ENCIRCLE study—the first transseptal TMVR system to reach approved human use. Dr. Daniels is the founder and CEO of Solo Pace Inc., a medical device startup developing transformative technologies for TAVR efficiency and post‑procedure heart block management. He previously led a 100‑physician cardiovascular organization and continues to shape the field through prolific research, publications, and faculty roles.","image":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/4FqLGwv5l5KnP42Q-6toojBNRGEKTDrprUK_xsYZSo8/460x460.webp","representativeOfPage":true},"address":{"@type":"PostalAddress","streetAddress":"1501 Trousdale Drive","addressLocality":"Burlingame","addressRegion":"CA","postalCode":"94010","addressCountry":"US"},"affiliation":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"mainEntityOfPage":{"@id":"https://www.sutterhealth.org/research/investigators/david-v-daniels-md-1049681155#profilepage"},"sameAs":"https://www.sutterhealth.org/find-provider/dr-david-daniels-1046234487"} ```